The IAPB Work Group on Diabetic Retinopathy (DR) was established in 2013. It is an ad hoc group of IAPB members committed to facilitating shared learning, supporting the development of tools and resources, and to informing and guiding IAPB’s advocacy efforts on DR.
Underpinning the work of the group is the need to foster greater collaboration among eye health INGOs and the diabetes sector.
The Work Group will:
Form and foster greater partnership and collaboration between NGOs who are active on DR;
Act as a forum for information exchange, learning and debate on DR;
Collate and disseminate evidence, knowledge and information and support new research and tools relating to the development, testing and scale up of innovative models for the prevention, treatment and management of DR;
As appropriate, support advocacy efforts to influence policy makers, practitioners and other key stakeholders on DR;
Monitor key events and policy processes relevant to DR and share relevant information, analysis and opportunities for engagement with the wider IAPB membership, other IAPB work groups, and the IAPB Board;
As appropriate, prepare policy papers, position statements and other external communications on DR for consideration by the IAPB Board.
Membership of the DR Work Group is open to all IAPB members engaged in DR.
All Work Group members are expected to actively contribute their particular expertise and knowledge to ensure the group meets its stated objectives.
For more information on the DR Work Group and how to get involved, get in touch!
Terms of Reference
The Diabetic Retinopathy Work Group’s terms of reference are currently being reviewed. You can read the ToR in review here.
This guidance aims to facilitate the monitoring of both eye and ear care services through presenting a set of core facility indicators along with considerations for analysis and use of routine health information